About Magnus Medical

Dr. Achal Singh Achrol is a neurosurgeon, executive leader, and entrepreneur with 20 years of experience spanning academia, medtech, and biotech. He began his career as neurosurgery faculty with a focus on clinical trials and translational neuroscience research. As a Principal Investigator, he has led clinical trials for noninvasive and minimally-invasive neurosurgical technologies in neuro-oncology, traumatic brain injury, stroke, and neurodegenerative and neuropsychiatric diseases.

Dr. Brandon Bentzley, is co-founder and Chief Scientific Officer of Magnus Medical. His interest in neuroscience led him to the Medical University of South Carolina (MUSC), the birthplace of clinical transcranial magnetic stimulation, where he completed his MD and PhD. He completed his residency and postdoctoral training at Stanford University, focusing on the development of SAINT technology. With over 15 years of experience in developing advanced automated systems, he has published in high-impact peer-reviewed journals, his clinical focus being in treatment-resistant depression and substance abuse disorders.

Vikram Lamba brings over three decades of global healthcare experience with both large pharmaceutical companies and startup entities. He is responsible for operations and business development. His career includes serving as CFO and head of business development at ImmPACT Bio USA and founding CFO at Civica, Inc. Earlier in his career, he held executive roles in M&A and as a divisional CFO at Bayer AG for over eight years. He received his MBA from the Asian Institute of Management after earning his undergraduate degree in mechanical engineering.

Romain Moreau-Gobard has been integral in building the company’s product and business strategy from inception. He has a distinguished career developing advanced medical imaging software and excels at overseeing the FDA 510(k) pathway to clearance. During his tenure at Magnus, the company achieved FDA clearance and Medicare reimbursements. Previously, he was Director of Engineering at HeartFlow for almost ten years, where he architected a novel software as a medical device (SAMD) and delivered the company’s first FDA-cleared product. He holds 15 US and international patents and a master’s degree in Artificial Intelligence.

Huyen Duong brings over 25 years of experience in leading clinical, quality, and regulatory affairs organizations at established medical technology companies and early startups. Previously, she was VP of Regulatory Affairs and Quality Assurance at Nesos Corporation, where she defined regulatory and clinical strategies to support global commercialization of their non-invasive neuromodulation platform. Prior to that, as Senior Director at Nevro Corporation, she supported pre- and post-market regulatory activities and managed over 20 clinical investigations. She has also held senior management positions in regulatory affairs at Boston Neuromodulation and Bausch and Lomb.

Matthew Wallace leads end-to-end customer engagement across the US markets. Since joining Magnus, he has built the commercial team, managed the healthcare system business, and developed the go-to-market strategy for the SAINT launch in outpatient settings. Prior to Magnus, he was the Vice President of Sales for the Americas and LATAM regions at Insightec. He has held numerous leadership roles launching truly disruptive innovations at medical device companies including Auris Health, iRhythm, Stereotaxis, and Intuitive Surgical.